CRT device implantation
Twenty-six patients (81%) received a CRT defibrillator; all others
received a CRT pacemaker. The devices were produced by one of two
manufacturers: Abbott (20, 62%) or Boston Scientific (12, 38%). The
quadripolar LV lead was placed transvenously in a coronary vein
overlying the LV free wall: 14 (44%) in a lateral vein and 18 (56%) in
a posterolateral vein.